Pacific Biosciences Of California Total Liabilities 2012-2025 | PACB
Pacific Biosciences Of California total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
|
Pacific Biosciences Of California Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $754 |
| 2023 | $1,045 |
| 2022 | $1,204 |
| 2021 | $1,216 |
| 2020 | $78 |
| 2019 | $93 |
| 2018 | $56 |
| 2017 | $58 |
| 2016 | $53 |
| 2015 | $58 |
| 2014 | $69 |
| 2013 | $67 |
| 2012 | $20 |
| 2011 | $27 |
|
Pacific Biosciences Of California Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $767 |
| 2025-06-30 | $764 |
| 2025-03-31 | $769 |
| 2024-12-31 | $754 |
| 2024-09-30 | $997 |
| 2024-06-30 | $1,017 |
| 2024-03-31 | $1,021 |
| 2023-12-31 | $1,045 |
| 2023-09-30 | $1,135 |
| 2023-06-30 | $1,206 |
| 2023-03-31 | $1,204 |
| 2022-12-31 | $1,204 |
| 2022-09-30 | $1,192 |
| 2022-06-30 | $1,194 |
| 2022-03-31 | $1,202 |
| 2021-12-31 | $1,216 |
| 2021-09-30 | $1,193 |
| 2021-06-30 | $988 |
| 2021-03-31 | $972 |
| 2020-12-31 | $78 |
| 2020-09-30 | $171 |
| 2020-06-30 | $172 |
| 2020-03-31 | $174 |
| 2019-12-31 | $93 |
| 2019-09-30 | $95 |
| 2019-06-30 | $95 |
| 2019-03-31 | $91 |
| 2018-12-31 | $56 |
| 2018-09-30 | $51 |
| 2018-06-30 | $52 |
| 2018-03-31 | $54 |
| 2017-12-31 | $58 |
| 2017-09-30 | $56 |
| 2017-06-30 | $62 |
| 2017-03-31 | $66 |
| 2016-12-31 | $53 |
| 2016-09-30 | $52 |
| 2016-06-30 | $53 |
| 2016-03-31 | $51 |
| 2015-12-31 | $58 |
| 2015-09-30 | $58 |
| 2015-06-30 | $63 |
| 2015-03-31 | $66 |
| 2014-12-31 | $69 |
| 2014-09-30 | $69 |
| 2014-06-30 | $69 |
| 2014-03-31 | $66 |
| 2013-12-31 | $67 |
| 2013-09-30 | $69 |
| 2013-06-30 | $34 |
| 2013-03-31 | $33 |
| 2012-12-31 | $20 |
| 2012-09-30 | $20 |
| 2012-06-30 | $22 |
| 2012-03-31 | $27 |
| 2011-12-31 | $27 |
| 2011-09-30 | $27 |
| 2011-06-30 | $28 |
| 2011-03-31 | $30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.709B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.686B | 27.89 |
| Intuitive Surgical (ISRG) | United States | $194.058B | 75.92 |
| IDEXX Laboratories (IDXX) | United States | $56.864B | 56.47 |
| Edwards Lifesciences (EW) | United States | $49.030B | 32.88 |
| IQVIA Holdings (IQV) | United States | $41.090B | 22.91 |
| Alcon (ALC) | Switzerland | $39.297B | 26.56 |
| Mettler-Toledo (MTD) | United States | $30.573B | 35.77 |
| DexCom (DXCM) | United States | $27.005B | 37.23 |
| STERIS (STE) | Ireland | $26.329B | 27.18 |
| Waters (WAT) | United States | $23.497B | 31.07 |
| Coloplast (CLPBY) | Denmark | $20.013B | 34.15 |
| Hologic (HOLX) | United States | $16.722B | 17.57 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.356B | 0.00 |
| Penumbra (PEN) | United States | $13.726B | 96.55 |
| Globus Medical (GMED) | United States | $12.566B | 26.37 |
| Masimo (MASI) | United States | $7.513B | 24.07 |
| Glaukos (GKOS) | United States | $6.575B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.270B | 19.92 |
| TransMedics (TMDX) | United States | $4.911B | 58.17 |
| Teleflex (TFX) | United States | $4.623B | 7.37 |
| LivaNova (LIVN) | United Kingdom | $3.451B | 18.64 |
| Veracyte (VCYT) | United States | $3.241B | 36.94 |
| Integer Holdings (ITGR) | United States | $2.988B | 14.03 |
| Alphatec Holdings (ATEC) | United States | $2.594B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.422B | 22.66 |
| Artivion (AORT) | United States | $2.051B | 94.11 |
| UFP Technologies (UFPT) | United States | $1.985B | 26.21 |
| Nihon Kohden (NHNKY) | Japan | $1.954B | 17.06 |
| PROCEPT BioRobotics (PRCT) | United States | $1.704B | 0.00 |
| AxoGen (AXGN) | United States | $1.440B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.429B | 0.00 |
| IRadimed (IRMD) | United States | $1.305B | 62.16 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.34 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.956B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.783B | 0.00 |
| SiBone (SIBN) | United States | $0.763B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.681B | 39.60 |
| Alpha Tau Medical (DRTS) | Israel | $0.651B | 0.00 |
| NeuroPace (NPCE) | United States | $0.578B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.485B | 13.40 |
| OrthoPediatrics (KIDS) | United States | $0.469B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.454B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 60.06 |
| Sight Sciences (SGHT) | United States | $0.349B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.201B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.175B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.169B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.144B | 0.00 |
| CVRx (CVRX) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Solana (HSDT) | United States | $0.128B | 0.00 |
| Neuronetics (STIM) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Accuray (ARAY) | United States | $0.098B | 0.00 |
| DarioHealth (DRIO) | United States | $0.083B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.40 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |